眼动脉多普勒预测子痫前期的研究综述
本文报告了眼动脉多普勒的检查方法,并汇总其在子痫前期预测中的临床应用研究。检索Embase和MEDLINE至2020年11月,发现高危妊娠中小型研究结果不一致,而两项大型观察性研究显示,在19–23周和35–37周妊娠中,眼动脉第二与第一收缩期峰值流速比值(PSV ratio)可提高子痫前期预测,且优于或改善其他生物标志物。
要点
- 眼动脉多普勒可反映颅内循环,子痫前期患者阻抗降低、流速升高。
- 需记录双眼波形以保证可重复性,波形特征为两个收缩期峰值。
- PSV比值在19–23周和35–37周可改善子痫前期预测。
核心结论
- 眼动脉多普勒是预测子痫前期的有用生物标志物。
研究设计与样本
- 综述,检索Embase和MEDLINE从建库至2020年11月,纳入报告眼动脉多普勒预测子痫前期的研究。
主要发现
- 两项高危妊娠小型研究(11–14周和20–28周)报告子痫前期与未患病孕妇眼动脉多普勒存在差异,提示有用。
- 一项高危妊娠18–23周小型研究报告子痫前期与未患病组眼动脉多普勒指标无显著差异。
- 两项大型观察性研究(19–23周和35–37周,非选择妊娠)报告需记录双眼波形以获得可重复结果。
- 子痫前期孕妇眼动脉波形第二与第一收缩期峰值流速比值升高。
- 19–23周研究中,PSV比值预测早产和足月子痫前期优于子宫动脉搏动指数、平均动脉压、血清胎盘生长因子和可溶性fms样酪氨酸激酶-1等单个生物标志物,并改善所有其他生物标志物的预测。
关键数值与推荐
- 需记录双眼眼动脉波形以获得可重复结果。
- 眼动脉波形特征为两个收缩期峰值,第二与第一收缩期峰值流速比值在子痫前期孕妇中升高。
- 19–23周PSV比值预测子痫前期优于子宫动脉搏动指数、平均动脉压、胎盘生长因子和可溶性fms样酪氨酸激酶-1等单个生物标志物。
- 35–37周PSV比值改善母体因素及母体因素联合平均动脉压、子宫动脉搏动指数、胎盘生长因子或血清胎盘生长因子的预测。
临床怎么用
- 眼动脉多普勒可作为子痫前期预测的辅助工具,尤其在中晚孕期结合其他临床和生物标志物使用。
- 操作时需记录双眼波形以确保结果可重复。
局限性
- 高危妊娠中小型研究结果不一致,部分研究未显示差异。
- 大型观察性研究为非选择妊娠,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ophthalmic artery is an easily accessible vessel for Doppler assessment that provides information on the less accessible intracranial circulation. In women with preeclampsia, compared with normotensive pregnant women, there is a decrease in impedance to flow and an increase in velocities in the flow velocity waveforms from the ophthalmic arteries. This study aimed to report the methodology for ophthalmic artery Doppler and summarize findings from the clinical implementation of such assessment in the prediction of preeclampsia. The Embase and MEDLINE were searched from inception to November 2020 to identify studies reporting on the use of ophthalmic artery Doppler in the prediction of preeclampsia. Of note, 2 small studies in high-risk pregnancies, one at 11 to 14 weeks' gestation and another at 20 to 28 weeks' gestation, reported differences between women who developed preeclampsia, compared with unaffected pregnancies, in ophthalmic artery Doppler and suggested that this is a useful biomarker for screening for preeclampsia. Another small study in high-risk pregnancies at 18 to 23 weeks' gestation reported that there was no marked difference in ophthalmic artery Doppler indices between the preeclampsia and unaffected groups. In addition, 2 recent, large observational studies in unselected pregnancies at 19 to 23 and 35 to 37 weeks' gestation, respectively, reported that, first, it is necessary to record waveforms from both eyes to get reproducible results; second, the waveform from the ophthalmic arteries is characterized by 2 systolic peaks and the ratio of the second to the first peak systolic velocity was increased in women who developed preeclampsia; third, in the study at 19 to 23 weeks' gestation, the peak systolic velocity ratio was superior to the uterine artery pulsatility index, mean arterial pressure, serum placental growth factor, and soluble fms-like tyrosine kinase-1 as individual biomarkers in the prediction of both preterm and term preeclampsia and the peak systolic velocity ratio improved the prediction of preeclampsia provided by all the other biomarkers; and fourth, in the study at 35 to 37 weeks' gestation, the peak systolic velocity ratio improved the prediction of subsequent development of preeclampsia provided by maternal factors alone and combinations of maternal factors with mean arterial pressure, uterine artery pulsatility index, placental growth factor, and serum placental growth factor. The ophthalmic artery Doppler provides a useful biomarker for the prediction of preeclampsia.
引用
- Nicolaides KH, Sarno M, Wright A, et al. Ophthalmic artery Doppler in the prediction of preeclampsia. Am J Obstet Gynecol. 2021. PMID: 34292158. doi:10.1016/j.ajog.2020.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。